Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_N06DA
Extra metadata
List of similar endpoints to
N06DA Anticholinesterases
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5521 | 2755 | 2766 |
| Unadjusted prevalence (%) | 2.12 | 1.87 | 2.45 |
| Mean age at first event (years) | 77.59 | 78.01 | 77.16 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.11 | 7.25 [5.80, 9.06] | 4.2e-68 | 2049 |
| 15 years | 0.05 | 7.30 [5.89, 9.05] | 2.8e-73 | 2042 |
| 5 years | 0.01 | 7.79 [6.87, 8.84] | <1e-100 | 1285 |
| 1 year | - | - | - | - |
Index endpoint: RX_N06DA – N06DA Anticholinesterases
GWS hits:
before N06DA Anticholinesterases
after N06DA Anticholinesterases
Loading survival analyses plot
Loading survival analyses table